• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

H2AJ是一种直接的雄激素受体靶基因,可调节雄激素诱导的细胞衰老并抑制前列腺癌细胞中的间充质标志物。

H2AJ Is a Direct Androgen Receptor Target Gene That Regulates Androgen-Induced Cellular Senescence and Inhibits Mesenchymal Markers in Prostate Cancer Cells.

作者信息

Heidari Horestani Mehdi, Atri Roozbahani Golnaz, Baniahmad Aria

机构信息

Institute of Human Genetics, Jena University Hospital, 07747 Jena, Germany.

出版信息

Cancers (Basel). 2025 Feb 25;17(5):791. doi: 10.3390/cancers17050791.

DOI:10.3390/cancers17050791
PMID:40075640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11898987/
Abstract

Prostate cancer (PCa) is a significant public health issue, particularly in developed countries. The androgen receptor (AR) plays a key role in regulating both the normal development and the proliferation of PCa. Bipolar androgen therapy, which involves treatment with supraphysiological androgen levels (SALs), has been shown to inhibit PCa growth. SAL induces cellular senescence in AR-positive PCa cell lines, human tumor samples, and xenografted mouse models. Transcriptome and chromatin immunoprecipitation (ChIP)-seq analysis, ChIP-qPCR, knockdown (KD), overexpression (OE), qRT-PCR, immunodetection, in situ histochemistry. Here, we show using ChIP-seq and RNA-seq that , a variant of the canonical histone H2A, is a direct target gene of AR that regulates cellular senescence and the formation of senescence-associated heterochromatin foci (SAHF). Accordingly, bioinformatic analyses reveal a large overlap of the H2AJ transcriptome with the cellular senescence score of PCa. Analyzing a large cohort of patient samples, the expression of is higher in tumor samples compared to normal samples suggesting growth-promoting activity. Interestingly, however, the expression is diminished in metastatic tumor samples, indicating that H2AJ inhibits the mesenchymal transition in PCa cells. Functionally, the KD of inhibits growth, whereas the overexpression promotes cell growth. Furthermore, these data suggest that H2AJ inhibits the expression of mesenchymal markers, in agreement with the low expression of in metastatic forms of tumors from patient cohorts. is a direct positively AR-regulated target gene induced by SALs that regulates cellular senescence, promotes growth, and inhibits the expression of mesenchymal markers.

摘要

前列腺癌(PCa)是一个重大的公共卫生问题,在发达国家尤为如此。雄激素受体(AR)在调节前列腺癌的正常发育和增殖中起着关键作用。双相雄激素疗法,即使用超生理雄激素水平(SALs)进行治疗,已被证明可抑制前列腺癌生长。SAL可诱导AR阳性前列腺癌细胞系、人肿瘤样本和异种移植小鼠模型中的细胞衰老。转录组和染色质免疫沉淀(ChIP)-seq分析、ChIP-qPCR、敲低(KD)、过表达(OE)、qRT-PCR、免疫检测、原位组织化学。在这里,我们使用ChIP-seq和RNA-seq表明,典型组蛋白H2A的一种变体,是AR的直接靶基因,可调节细胞衰老和衰老相关异染色质灶(SAHF)的形成。因此,生物信息学分析揭示了H2AJ转录组与前列腺癌的细胞衰老评分有很大重叠。分析大量患者样本队列,与正常样本相比,肿瘤样本中H2AJ的表达更高,表明其具有促进生长的活性。然而,有趣的是,在转移性肿瘤样本中其表达降低,这表明H2AJ抑制前列腺癌细胞的间充质转化。在功能上,H2AJ的敲低抑制生长,而过表达则促进细胞生长。此外,这些数据表明H2AJ抑制间充质标志物的表达,这与患者队列中转移性肿瘤形式中H2AJ的低表达一致。H2AJ是一种由SALs诱导的直接受AR正向调控的靶基因,可调节细胞衰老、促进生长并抑制间充质标志物的表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1e/11898987/3cc9cf19ff00/cancers-17-00791-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1e/11898987/b4f366e90a5c/cancers-17-00791-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1e/11898987/6af15f074a64/cancers-17-00791-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1e/11898987/0891b51a6f7a/cancers-17-00791-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1e/11898987/f1e4000f4aff/cancers-17-00791-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1e/11898987/3cc9cf19ff00/cancers-17-00791-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1e/11898987/b4f366e90a5c/cancers-17-00791-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1e/11898987/6af15f074a64/cancers-17-00791-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1e/11898987/0891b51a6f7a/cancers-17-00791-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1e/11898987/f1e4000f4aff/cancers-17-00791-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1e/11898987/3cc9cf19ff00/cancers-17-00791-g005a.jpg

相似文献

1
H2AJ Is a Direct Androgen Receptor Target Gene That Regulates Androgen-Induced Cellular Senescence and Inhibits Mesenchymal Markers in Prostate Cancer Cells.H2AJ是一种直接的雄激素受体靶基因,可调节雄激素诱导的细胞衰老并抑制前列腺癌细胞中的间充质标志物。
Cancers (Basel). 2025 Feb 25;17(5):791. doi: 10.3390/cancers17050791.
2
Functional circuits of LYL1 controlled by supraphysiological androgen in prostate cancer cells to regulate cell senescence.在前列腺癌细胞中,超生理水平雄激素控制LYL1的功能回路以调节细胞衰老。
Cell Commun Signal. 2024 Dec 12;22(1):590. doi: 10.1186/s12964-024-01970-7.
3
The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer.时钟基因 BHLHE40 和非典型 CCNG2 作为前列腺癌中一种新的肿瘤抑制途径,控制雄激素诱导的细胞衰老。
J Exp Clin Cancer Res. 2024 Jun 20;43(1):174. doi: 10.1186/s13046-024-03097-6.
4
The oncogenic lncRNA MIR503HG suppresses cellular senescence counteracting supraphysiological androgen treatment in prostate cancer.致癌长链非编码RNA MIR503HG通过对抗前列腺癌中超生理水平雄激素治疗来抑制细胞衰老。
J Exp Clin Cancer Res. 2024 Dec 16;43(1):321. doi: 10.1186/s13046-024-03233-2.
5
The androgen receptor-lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells.雄激素受体-长链非编码 RNA SAT1-AKT-p15 轴介导雄激素诱导的前列腺癌细胞衰老。
Oncogene. 2022 Feb;41(7):943-959. doi: 10.1038/s41388-021-02060-5. Epub 2021 Oct 19.
6
The lncRNAs PART1 and ADAMTS9-AS2 act in an antithetic manner on AR signaling and induction of cellular senescence in prostate cancer cells.长链非编码RNA PART1和ADAMTS9-AS2以相反的方式作用于前列腺癌细胞中的雄激素受体信号传导和细胞衰老诱导。
Int J Surg. 2025 May 1;111(5):3646-3664. doi: 10.1097/JS9.0000000000002334.
7
The Novel Direct AR Target Gene Annexin A2 Mediates Androgen-Induced Cellular Senescence in Prostate Cancer Cells.新型直接雄激素受体靶基因膜联蛋白A2介导前列腺癌细胞中雄激素诱导的细胞衰老。
Biochem Genet. 2024 Nov 19. doi: 10.1007/s10528-024-10953-9.
8
Androgen-Induced MIG6 Regulates Phosphorylation of Retinoblastoma Protein and AKT to Counteract Non-Genomic AR Signaling in Prostate Cancer Cells.雄激素诱导的 MIG6 通过调节视网膜母细胞瘤蛋白和 AKT 的磷酸化来拮抗前列腺癌细胞中的非基因组 AR 信号。
Biomolecules. 2022 Jul 29;12(8):1048. doi: 10.3390/biom12081048.
9
Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway.超生理水平的雄激素通过Src-Akt信号通路诱导人前列腺癌细胞发生细胞衰老。
Mol Cancer. 2014 Sep 12;13:214. doi: 10.1186/1476-4598-13-214.
10
Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer.雄激素受体激动剂和拮抗剂介导前列腺癌细胞衰老的机制
Cancers (Basel). 2020 Jul 8;12(7):1833. doi: 10.3390/cancers12071833.

引用本文的文献

1
Cellular senescence in cancer: from mechanism paradoxes to precision therapeutics.癌症中的细胞衰老:从机制悖论到精准治疗
Mol Cancer. 2025 Aug 8;24(1):213. doi: 10.1186/s12943-025-02419-2.

本文引用的文献

1
The oncogenic lncRNA MIR503HG suppresses cellular senescence counteracting supraphysiological androgen treatment in prostate cancer.致癌长链非编码RNA MIR503HG通过对抗前列腺癌中超生理水平雄激素治疗来抑制细胞衰老。
J Exp Clin Cancer Res. 2024 Dec 16;43(1):321. doi: 10.1186/s13046-024-03233-2.
2
Functional circuits of LYL1 controlled by supraphysiological androgen in prostate cancer cells to regulate cell senescence.在前列腺癌细胞中,超生理水平雄激素控制LYL1的功能回路以调节细胞衰老。
Cell Commun Signal. 2024 Dec 12;22(1):590. doi: 10.1186/s12964-024-01970-7.
3
Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells.
雄激素受体单体和二聚体调节前列腺癌细胞中相反的生物学过程。
Nat Commun. 2024 Sep 3;15(1):7675. doi: 10.1038/s41467-024-52032-y.
4
The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer.时钟基因 BHLHE40 和非典型 CCNG2 作为前列腺癌中一种新的肿瘤抑制途径,控制雄激素诱导的细胞衰老。
J Exp Clin Cancer Res. 2024 Jun 20;43(1):174. doi: 10.1186/s13046-024-03097-6.
5
Senescence-Associated Heterochromatin Foci Suppress γ-H2AX Focus Formation Induced by Radiation Exposure.衰老相关异染色质焦点抑制辐射暴露诱导的 γ-H2AX 焦点形成。
Int J Mol Sci. 2024 Mar 15;25(6):3355. doi: 10.3390/ijms25063355.
6
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.双相雄激素治疗联合纳武利尤单抗治疗转移性去势抵抗性前列腺癌:COMBAT Ⅱ期试验。
Nat Commun. 2024 Jan 2;15(1):14. doi: 10.1038/s41467-023-44514-2.
7
JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles.JASPAR 2024:转录因子结合谱开放获取数据库的 20 周年纪念
Nucleic Acids Res. 2024 Jan 5;52(D1):D174-D182. doi: 10.1093/nar/gkad1059.
8
High-throughput data and modeling reveal insights into the mechanisms of cooperative DNA-binding by transcription factor proteins.高通量数据和建模揭示了转录因子蛋白协同 DNA 结合机制的深入见解。
Nucleic Acids Res. 2023 Nov 27;51(21):11600-11612. doi: 10.1093/nar/gkad872.
9
Bipolar Androgen Therapy: When Excess Fuel Extinguishes the Fire.双相雄激素疗法:当过量燃料扑灭火焰时。
Biomedicines. 2023 Jul 24;11(7):2084. doi: 10.3390/biomedicines11072084.
10
Beyond SAHF: An integrative view of chromatin compartmentalization during senescence.超越 SAHF:衰老过程中染色质区室化的综合观点。
Curr Opin Cell Biol. 2023 Aug;83:102206. doi: 10.1016/j.ceb.2023.102206. Epub 2023 Jul 12.